7noObjectives: To evaluate spectra and their correlations with clinical symptoms of local field potentials (LFP) acquired from wide- and close-spaced contacts (i.e. between contacts 0–3 or LFP03, and contacts 1–2 or LFP12 respectively) on the same DBS electrode within the subthalamus (STN) in Parkinson's disease (PD), before and after levodopa administration. Methods: LFP12 and LFP03 were recorded from 20 PD patients. We evaluated oscillatory power, local and switched phase-amplitude coupling (l- and Sw-PAC) and correlation with motor symptoms (UPDRSIII). Results: Before levodopa, both LFP03 and LFP12 power in the α band inversely correlated with UPDRSIII. Differences between contacts were found in the low-frequency bands power. After levod...
Studies describing subthalamic (STN) local field potentials (LFPs) recorded during deep brain stimul...
Parkinson's disease is treated pharmacologically with dopamine replacement medication and, more rece...
Parkinson's disease is treated pharmacologically with dopamine replacement medication and, more rece...
New adaptive systems for deep brain stimulation (DBS) could in the near future optimize stimulation ...
New adaptive systems for deep brain stimulation (DBS) could in the near future optimize stimulation ...
New adaptive systems for deep brain stimulation (DBS) could in the near future optimize stimulation ...
In Parkinson’s disease (PD) levodopa-associated changes in the power and long-range temporal correla...
Strong synchronization of neuronal activity occurs in the 8-35 Hz band in the subthalamic nucleus (S...
How deep brain stimulation (DBS) acts and how the brain responds to it remains unclear. To investiga...
Parkinson’s disease (PD) is the second most common neurodegenerative disorder in the US, with a prev...
Local field potentials (LFP) recorded from the subthalamic nucleus in patients with Parkinson's dise...
Parkinson’s disease (PD) is characterized by the progressive loss of dopaminergic nigral neurons res...
Parkinson’s Disease (PD) leads to heterogeneous clinical symptoms. The underlying electrophysiologic...
International audienceIntroduction: The subthalamic nucleus (STN) is the main target for deep brain ...
Studies describing subthalamic (STN) local field potentials (LFPs) recorded during deep brain stimul...
Studies describing subthalamic (STN) local field potentials (LFPs) recorded during deep brain stimul...
Parkinson's disease is treated pharmacologically with dopamine replacement medication and, more rece...
Parkinson's disease is treated pharmacologically with dopamine replacement medication and, more rece...
New adaptive systems for deep brain stimulation (DBS) could in the near future optimize stimulation ...
New adaptive systems for deep brain stimulation (DBS) could in the near future optimize stimulation ...
New adaptive systems for deep brain stimulation (DBS) could in the near future optimize stimulation ...
In Parkinson’s disease (PD) levodopa-associated changes in the power and long-range temporal correla...
Strong synchronization of neuronal activity occurs in the 8-35 Hz band in the subthalamic nucleus (S...
How deep brain stimulation (DBS) acts and how the brain responds to it remains unclear. To investiga...
Parkinson’s disease (PD) is the second most common neurodegenerative disorder in the US, with a prev...
Local field potentials (LFP) recorded from the subthalamic nucleus in patients with Parkinson's dise...
Parkinson’s disease (PD) is characterized by the progressive loss of dopaminergic nigral neurons res...
Parkinson’s Disease (PD) leads to heterogeneous clinical symptoms. The underlying electrophysiologic...
International audienceIntroduction: The subthalamic nucleus (STN) is the main target for deep brain ...
Studies describing subthalamic (STN) local field potentials (LFPs) recorded during deep brain stimul...
Studies describing subthalamic (STN) local field potentials (LFPs) recorded during deep brain stimul...
Parkinson's disease is treated pharmacologically with dopamine replacement medication and, more rece...
Parkinson's disease is treated pharmacologically with dopamine replacement medication and, more rece...